Aurobindo Pharma jumps 91%, others gain up to 94% this year: Why are pharma stocks rising - Explained

Pharma stocks in India have been outperforming the benchmark index Nifty50 this year. Factors driving the gains include improved performance in the US generics market, robust performance in branded markets, lower raw material costs, and market share gains in new products.

Related Keywords

India ,United States ,American ,Shrey Jain ,Pravesh Gour ,Kaushik Dani ,Manoj Dalmia ,Aurobindo Pharma ,Glenmark Pharma ,Prathamesh Masdekar ,Pfizer ,Gland Pharma ,Nifty Pharma ,View Full Image ,Deep Discount Broker ,Indian Pharma Industry ,Proficient Equities ,Fund Manager ,Abans Investment Managers ,North American ,Senior Technical Analyst ,Swastika Investmart ,Pharma Stocks ,Cipla ,Sun Pharma ,Dr Reddys Labs ,Divis Labs ,Lupin ,